- PLN5.39bn
- PLN6.48bn
- PLN2.41bn
Annual income statement for Diagnostyka SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Revenue | |||
| Total Revenue | 1,588 | 1,950 | 2,410 |
| Cost of Revenue | |||
| Gross Profit | 1,227 | 1,530 | 1,905 |
| Selling / General / Administrative Expenses | |||
| Depreciation and Amortization | |||
| Unusual Expense / Income | |||
| Other Operating Expenses | |||
| Total Operating Expenses | 1,354 | 1,612 | 2,028 |
| Operating Profit | 234 | 339 | 383 |
| Total Net Non Operating Interest Income / Expense | |||
| Other Net Non Operating Costs | |||
| Net Income Before Taxes | 174 | 291 | 317 |
| Provision for Income Taxes | |||
| Net Income After Taxes | 130 | 232 | 262 |
| Minority Interest | |||
| Net Income Before Extraordinary Items | |||
| Net Income | 123 | 223 | 252 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||
| Income Available to Common Shareholders Including Extraordinary Items | |||
| Diluted Net Income | 123 | 223 | 252 |
| Diluted Weighted Average Shares | |||
| Basic EPS Including Extraordinary Items | |||
| Diluted EPS Including Extraordinary Items | |||
| Diluted EPS Excluding Extraordinary Items | |||
| Normalised Income Before Taxes | |||
| Normalised Income After Taxes | |||
| Normalised Income Available to Common Shareholders | |||
| Diluted Normalised EPS | 3.55 | 6.56 | 7.29 |
| Dividends per Share |